New method for on‑board drug manufacturing
Scientists have devised a process that enables astronauts to grow genetically engineered plants capable of producing pharmaceutical compounds on demand. The system operates within closed growth modules, allowing the cultivation of medicinal plants in microgravity.
Implications for long‑duration spaceflight
Generating medicines in situ reduces the need for large medical inventories and enhances crew safety on missions to the Moon, Mars, or extended stays aboard the International Space Station. Supply chains that span months or years become less critical when essential drugs can be synthesized on the spacecraft.
Applications on Earth
The technology also holds promise for low‑resource regions where conventional drug manufacturing is unavailable. Local cultivation of therapeutic plants could lower costs and improve access to essential medicines.
Future development
Planned experiments will evaluate plant growth and compound yield under microgravity, while regulatory assessments will ensure the safety of the extracted medicines. Space agencies and commercial partners are exploring collaborations to integrate this capability into upcoming exploration architectures.